# ​Sickle Cell Disease Regional Care Excellence (SoRCE) Program

Source: https://welltoldgrants.com/grants/hrsa-26-052-sickle-cell-disease-regional-care-excellence-sorce-program/  
Official notice: https://www.grants.gov/search-results-detail/360997

> Health Resources and Services Administration offered grants of up to $950,000 to nonprofits and colleges and universities. It expected to make about 7 awards worth $6.7 million in total. Applications closed on July 8, 2026.

| Field | Value |
|---|---|
| Opportunity number | HRSA-26-052 |
| Agency | Health Resources and Services Administration |
| Status | Forecast |
| Deadline | July 8, 2026 |
| Award ceiling | $950,000 |
| Award floor | not stated |
| Expected awards | 7 |
| Total funding | $6.7 million |
| Cost sharing | not required |
| Assistance Listings | 93.365 |

## Who can apply

- Public and State controlled institutions of higher education
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Hospitals or clinicsHealth centers.

## What the grant funds

Sickle Cell Disease Regional Care Excellence Program (SoRCE) is to improve the health of people with sickle cell disease (SCD) by expanding access to care, improving the quality of care, and tracking quality of life indicators. There are approximately 100,000 people in the United States with SCD. Treatment starting in early childhood can prevent or reduce complications such as severe pain episodes, silent strokes, and premature death. Despite universal identification at birth, fewer than half of children with SCD receive needed treatment. As these children become adolescents and transition to adulthood many are not appropriately identified as candidates for disease-modifying therapies, in part because their doctors are still learning how to use the latest treatments. The program is made up of seven regions with one award recipient per region serving as a Regional Coordinating Hub (RCH). Each award recipient will work with clinical and community-based partners in their region and engage in continuous quality improvement (CQI) initiatives to improve access and quality of care.

## Questions people ask

### Is HRSA-26-052 still open?

No. It closed on July 8, 2026.

### Who can apply for ​Sickle Cell Disease Regional Care Excellence (SoRCE) Program?

Health Resources and Services Administration accepted applications from nonprofits and colleges and universities. The notice adds further conditions, so read its eligibility section.

### What is the deadline for ​Sickle Cell Disease Regional Care Excellence (SoRCE) Program?

Closed July 8, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $950,000 each. About $6.7 million in total across about 7 awards.

### Who has won Sickle Cell Treatment Demonstration Program grants before?

The largest recipients over five fiscal years were University of Alabama at Birmingham, The Johns Hopkins University, The Washington University. The program made 5 awards worth $27.0 million in that time.